Back

Energy Flux Regulates Cell Death Induced by California Serogroup Orthobunyaviruses

Francomacaro, L. M.; Matey, H.; Beauchemin, K. S.; Evans, A. B.; Supattapone, S.

2026-03-14 microbiology
10.64898/2026.03.13.711679 bioRxiv
Show abstract

The California serogroup (CSG) of orthobunyaviruses includes neuroinvasive viruses with varying pathogenicity. La Crosse virus (LACV) is a leading cause of pediatric arboviral encephalitis in the USA, while Inkoo virus (INKV) is widespread in Northern Europe but rarely causes disease. The reassortment potential of CSG viruses raises concerns about emerging virulent strains and highlights the need to develop therapies that are broadly effective against multiple CSG viruses. To identify host factors mediating viral neurotoxicity, we performed genome-wide CRISPR-Cas9 knockout screens in human neuroblastoma cells infected with LACV or INKV. Analysis revealed largely overlapping host dependency factors for both viruses. Unexpectedly, the screens identified mitochondrial energy production as a major pathway required for both LACV- and INKV-induced cell death. Reducing host cell energy production with mild hypothermia or sugar source substitution prolonged cell survival during viral infection with additive effects mediated by different mechanisms. Both manipulations also protected neuroblastoma cells from the Bunyamwera virus (BUNV), a non-CSG orthobunyavirus; and mild hypothermia protected mature human neurons from LACV. These results highlight host energy metabolism as a key modulator of CSG virus cytotoxicity and suggest novel avenues for general non-invasive therapeutic intervention against current and future strains of these and other orthobunyaviruses.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
PLOS Pathogens
721 papers in training set
Top 0.7%
17.0%
2
PLOS Biology
408 papers in training set
Top 0.1%
14.3%
3
Nature Communications
4913 papers in training set
Top 12%
13.9%
4
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 15%
4.7%
5
Virus Evolution
140 papers in training set
Top 0.3%
4.2%
50% of probability mass above
6
mBio
750 papers in training set
Top 4%
4.0%
7
Journal of Virology
456 papers in training set
Top 1%
4.0%
8
eLife
5422 papers in training set
Top 28%
3.5%
9
Science
429 papers in training set
Top 9%
3.5%
10
The Lancet Infectious Diseases
71 papers in training set
Top 0.8%
3.5%
11
Nature Microbiology
133 papers in training set
Top 2%
2.0%
12
Cell Host & Microbe
113 papers in training set
Top 3%
2.0%
13
Viruses
318 papers in training set
Top 2%
1.8%
14
Cell Reports
1338 papers in training set
Top 22%
1.8%
15
Cell
370 papers in training set
Top 12%
1.6%
16
iScience
1063 papers in training set
Top 23%
1.2%
17
Science Translational Medicine
111 papers in training set
Top 5%
0.9%
18
Science Advances
1098 papers in training set
Top 26%
0.9%
19
Genome Medicine
154 papers in training set
Top 7%
0.9%
20
Emerging Microbes & Infections
74 papers in training set
Top 2%
0.8%
21
Current Biology
596 papers in training set
Top 14%
0.8%
22
Cell Reports Medicine
140 papers in training set
Top 8%
0.7%
23
Nature
575 papers in training set
Top 16%
0.7%